Daniel Iglesias-Serret

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 25, 2025
Targeting prohibitins activates the ISR through DELE1-HRI by impairing protein import into the mitochondrial matrix.

Ismael Sánchez-Vera, Ana M Cosialls, Nekane Maritorena-Hualde

|Aug 26, 2023
Purine Nucleotide Alterations in Tumoral Cell Lines Maintained with Physiological Levels of Folic Acid.

Claudia Cano-Estrada, Lidia de Benito-Gómez, Paula Escudero-Ferruz

|May 13, 2023
The Prohibitin-Binding Compound Fluorizoline Activates the Integrated Stress Response through the eIF2α Kinase HRI.

Ismael Sánchez-Vera, Sonia Núñez-Vázquez, José Saura-Esteller

Pageof 1